ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2026
The Increased Activity of CaV3.2 Channels Contributes to Nociceptors' Hyperexcitability and Chronic Neuropathic Pain Following Spinal Cord Injury in Mice.
Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following spinal cord injury (SCI), up to 60-70% of patients develop chronic neuropathic pain. SCI-induced neuropathic pain (SCI-NP) is often lifelong and therapeutically intractable, leading to a severe decline in quality of life and increased risk for depression, anxiety, and addiction. Studies in preclinical rat models of SCI support the contribution of nociceptors' hyperexcitability and their spontaneous activity (SA) in driving the development/maintenance of SCI-NP and suggest that reducing nociceptors' hyperexcitability could provide a therapeutic strategy to treat SCI-NP. Previous data from our laboratory collected from SCI rats showed that the increased activity of T-type calcium channels induced by SCI contributes to drive nociceptors' hyperexcitability and their SA in vitro and pain hypersensitivity in vivo, supporting a contribution of T-type calcium channels in driving nociceptors' hyperexcitability and the development/maintenance of SCI-NP. The data presented here in a mouse model of SCI confirm a similar increase in nociceptors' excitability, supporting a conserved mechanism(s) between species. Data collected in SCI CaV3.2-/- mice showed reduced nociceptors' excitability in vitro and reduced mechanical hypersensitivity and spontaneous pain in vivo as compared with SCI wild-type mice, consistent with a contribution of CaV3.2 channels in driving nociceptors' hyperexcitability and SCI-NP. Data with behavioral pharmacology in vivo showed that TTA-P2 (a blocker of T-type calcium channels) and gabapentin (inhibitor of trafficking of high voltage-activated calcium channels) reduced mechanical hypersensitivity in male and female SCI mice, while only a TTA-P2-sensitive component of spontaneous pain was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.